Loading
Latest filing published 16 Jun 2017 for Capha Pharmaceuticals Inc. (Formerly FPS PHARMA INC.).
No signal scores available.
Only one filing by Kyle Joseph Remenda is known so far (16 June 2017): a transaction, in Capha Pharmaceuticals Inc. (Formerly FPS PHARMA Inc.). That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.